Sala Mira, Iván(Universitat Politècnica de València, 2016-12-22)
[ES] El páncreas artificial persigue mejorar los niveles de glucemia en las personas con
diabetes mellitus tipo 1. Sin embargo, uno de los principales desafíos de control, al que
debe hacer frente el páncreas artificial, ...
Sanz Diaz, Ricardo; Sala-Mira, Iván; Furió-Novejarque, Clara; García Gil, Pedro José; Diez, José-Luís; Bondía Company, Jorge(Elsevier, 2024-08-24)
[EN] Artificial pancreas systems should be designed considering different patient profiles, which is challenging from a control theory perspective. In this paper, a flexible-hybrid dual-hormone control algorithm for an ...
Sala-Mira, Iván; García Gil, Pedro José; Diez, José-Luís; Bondia, Jorge(Elsevier, 2022-11)
[EN] Background and Objectives
Hybrid artificial pancreas systems outperform current insulin pump therapies in blood glucose regulation in type 1 diabetes. However, subjects still have to inform the system about meals ...
Sala Mira, Iván(Universitat Politècnica de València, 2023-04-03)
[ES] Las infusiones exógenas de insulina son vitales para las personas con diabetes tipo 1 para suplir parcialmente la incapacidad del páncreas de secretar insulina. Sin embargo, las terapias intensivas actuales pueden ...
[EN] Carbohydrate counting is not only a burden for patients with type 1 diabetes, but estimation errors in meal announcement could also degrade the outcomes of the current hybrid closed-loop systems. Therefore, removing ...
[EN] Background and objective: Hybrid automated insulin delivery systems rely on carbohydrate counting to improve postprandial control in type 1 diabetes. However, this is an extra burden on subjects, and it introduces a ...